On November 30th, Fluicell published the company’s quarterly report for Q3-23.
Fluicell AB (publ) (”Fluicell” or “the Company”) offers innovative R&D instruments for both single-cell analysis and 3D bioprinting business...
On August 18th, Fluicell published the company’s quarterly report for Q2-23.
On May 12th, Fluicell published the company’s quarterly report for Q1-23.
On February 24th, Fluicell published the company’s quarterly report for Q4-22.
Fluicell offers innovative R&D instruments for single-cell analysis and 3D bioprinting, a business area which we forecast will enter a fast-...
Summary of Operating Activities During Q3-22, the revenue amounted to SEK 0.
On the 6th of October 2022, Fluicell (“Fluicell” or the “company”) announced that the company has received an order regarding Biopixlar AER ...
Today, 18th of August, Fluicell released its quarterly report for the second quarter 2022.
On June 22, 2022, Fluicell announced that they have been selected as one out of ten most innovative companies within 3D printing by the indu...
Our analyst summarizes the investment case: “Fluicell offers innovative R&D instruments for single-cell analysis and 3D bioprinting, a busin...
